Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-α and interleukin-6 in patients with sepsis
- 1 September 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 27 (9), 1814-1818
- https://doi.org/10.1097/00003246-199909000-00018
Abstract
Objectives: To determine correlations and predictive strength of surrogate markers (body temperature, leukocyte count, C-reactive protein [CRP], and procalcitonin [PCT]) with elevated levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in septic patients. Design: Prospective consecutive case series. Setting: Surgical intensive care unit (ICU) of a university hospital. Patients: A total of 175 patients experiencing intensive care unit stays >48 hrs categorized for sepsis according to ACCP/SCCM Consensus Conference criteria. Measurements and Main Results: CRP and PCT were both significantly correlated with TNF-α and IL-6. Based on the area-under-the-curve of the receiver operating characteristics curves, predicting capability was highest for PCT (0.814 for TNF-α >40 pg/mL and 0.794 for IL-6 >500 pg/mL), moderate with CRP (0.732 and 0.716, respectively), and lowest for leukocyte count (0.493 and 0.483, respectively) and body temperature (0.587 and 0.589, respectively). Sensitivity, specificity, positive, and negative predictive values and test effectiveness all followed this same pattern of being highest for PCT followed by CRP, with leukocyte count and body temperature being lowest. Conclusion: PCT may be an early and better marker of elevated cytokines than the more classic criteria of inflammation.Keywords
This publication has 21 references indexed in Scilit:
- Why Sepsis Trials FailJAMA, 1996
- An overview of mortality risk prediction in sepsisCritical Care Medicine, 1995
- Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of PathogenesisAnnals of Internal Medicine, 1994
- Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis SyndromeAnnals of Internal Medicine, 1993
- Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsisCritical Care Medicine, 1993
- Serum Cytokine Levels in Human Septic ShockChest, 1993
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993
- A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative SepsisJAMA, 1991
- Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against EndotoxinNew England Journal of Medicine, 1991
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987